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Comparative Study in Two Institutions Between IVUS and Pressure Wire in the
Assessment of Intermediate Lesions
Jose M De la Torre Hernandez1, Ramon Lopez Palop2, Tamara Garcia Camarero1,
Pilar Carrillo2, Gonzalo Martin Gorria1, Araceli Frutos2, Blanca Arnaez1, Julian
Roldan2
1Hemodinamica, Hospital U. Marques de Valdecilla, Santander, Spain; 2Hospital U.
San Juan, Alicante, Spain
Background: The assessment of intermediate coronary lesions can be done with IVUS
or pressure-wire derived fractional flow reserve (FFR). Both have their advantages
and limitations. There are not randomized trials comparing these strategies. There are
small registries from the same center but subjected to important biases.
Methods: In two public institutions the strategy for intermediate lesion evaluation has
been different in previous years, in one was based in IVUS (IVUS Center) and in the
other was based in FFR (FFR Center). We have compared the outcome of patients with
intermediate lesions (40-60%) assessed in a 4 years period (2006-2009) in both centers.
The criteria for revascularization was FFR <0.75 and a minimum lumen area <4mm2
in vessels >3 mm and <3.5 mm2 in vessels 2.5-3 mm.
Results: In the FFR center 471 patients were included (545 lesions studied). After FFR
measurement, 364 (67%) lesions were left untreated in 321 patients. In the IVUS center
352 pts were included (429 lesions studied). After IVUS examination, 228 (53%)
lesions were left untreated in 182 pts (p=0.0001 vs FFR center). The clinical and
angiographic profile of both groups was well balanced without significant differences.
In the FFR-deferred group at 12 months there were 3 cardiac deaths (not lesion related),
none lesion related infarctions and 7 (1.9%) target lesions were treated in 7 (2.1%) pts.
In 8 pts revascularization was done in other lesions and in 3 pts over a restenotic lesion.
In the IVUS-deferred group at 12 months there were 2 cardiac deaths (not lesion
related), none lesion related infarctions and 2 (0.9%) target lesions were treated in 2
(1%) pts (p=0.5 vs FFR center). In 5 patients revascularization was done in new lesions
and in other 5 pts over a restenotic lesion.
Conclusion: The assessment of intermediate lesions with IVUS induce a higher degree
of revascularization (47% vs 33%). At one year follow up both strategies result safe
with a very low rate of lesion-related events, only a 1-2% of revascularizations.
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The Relationship Between Long-term Clinical Outcomes and Serial Atheroma
Changes by Volumetric Intravascular Ultrasound
Atsushi Hirohata, Keizo Yamamoto, Eiki Hirose, Yuko Toyama, Yuhei Kobayashi,
Fumihiko Sano, Keisuke Ohkawa, Hiroya Takafuji, Yuzuru Iino, Minako Ohara, Ryo
Yoshioka, Hiroyuki Takinami, Hideyuki Hayashi, Tohru Ohe
Cardiovascular Medicine, The Sakakibara Heart Institute of Okayama, Okayama,
Japan
Background: Intravascular ultrasound (IVUS) is widely used as an endpoint in studies
aimed at reducing progression or regression of coronary artery disease. However, the
relationship between long-term clinical outcomes and serial atheroma changes by IVUS
remains unclear.
Methods: Serial volumetric IVUS examinations (baseline and 14 months) were
performed in 338 stable angina pectoris patients with native coronary artery lesions.
When these patients underwent percutaneous coronary intervention for culprit lesions,
IVUS was also performed in their non-culprit vessels (without angiographically
documented coronary stenosis [<50%]). We compared 4-year clinical outcomes,
including major adverse cardio- and cerebrovascular events (MACCE), and annual
progression rate of atherosclerosis, assessed by serial volumetric IVUS (mean lengths:
43mm).
Results: The 4-year cumulative rate of MACCE was 21.3%. Coronary events were
adjudicated to be related to culprit lesions in 10.4% of patients and to non-culprit
lesions in 8.9%. By adjusting for validated prognosticators, diabetes (baseline
HbA1c>7.5%), prior history of cardiovascular disease, high age (>70 years), 3-vessel
disease, and large annual atheroma progression (atheroma volume >15% / year) were
identified as poor predictors of MACCE, whereas Statin and ARB/ACE administration
were identified as good predictors. Additionally, patients with adverse events (n=62)
had larger annual atheroma progression than the rest of the population (23.8±18.7%
vs. 2.1±13.8%, P<0.001).
Conclusion: Atheroma volume changes, assessed by volumetric IVUS, seem to be a
reliable surrogate for future major adverse cardio- and cerebrovascular events in this
study cohort.
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Extent, Characterization, and Clinical Implications of Untreated Lesions with
High Plaque Burden after Successful Percutaneous Coronary Intervention: A
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Background: In patients (pts) with acute coronary syndromes (ACS), residual
atherosclerotic disease after successful percutaneous coronary intervention (PCI) may
predispose to future major adverse cardiovascular events (MACE).
Methods: In PROSPECT, following successful PCI of all clinically significant lesions
in pts with ACS, three-vessel gray-scale and radiofrequency-intravascular ultrasound
(IVUS) was performed. Analyzable images were available in 660 pts, followed for a
median of 3.4 years.
Results: Total plaque burden was 49.6 ± 4.2% in imaged segments. At least one lesion
with a plaque burden ≥70% (PB70) was found in 220 (33%) patients. History of PCI
(OR 1.79 [1.07, 2.99]) and angiographic three-vessel disease (1.77 [1.24, 2.52]) were
independent predictors of pts with PB70 lesions. IVUS findings and clinical outcomes
are shown in the Table. Among imaged nonculprit lesions, the proportion of PB70
lesions causing clinical events was significantly greater than non-PB70 lesions (8.7%
vs. 1.0%, p <0.0001).
Baseline Imaging and 3-Year Outcomes in Patients with and without PB70
Lesions
Conclusion: Following successful PCI of all angiographically significant lesions,
overall atherosclerotic burden is high and PB70 lesions are frequently present in the
proximal and mid-coronary tree. Pts with PB70 lesions have a greater disease burden
and are at increased risk for future MACE.
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Volumetric Intravascular Ultrasound Assessment Of Mechanisms and Results
Of Stent Expansion In Heart Transplant Patients
Elias Sanidas1, Akiko Maehara1, Gary S Mintz1, Takashi Kubo2, Anuj Gupta3,
Bimmer Claessen1, Diaa Hakim1, Reni Rusinova1, Giora Weisz1, Mark A Apfelbaum1,
Martin B Leon1, Martin Fahy1, Jeffrey W Moses1, Donna Mancini1, LeRoy E
Rabbani1
1Columbia University Medical Center and the Cardiovascular Research Foundation,
New York, NY; 2Department of Cardiovascular Medicine, Wakayama Medical
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Background: We investigated mechanisms and potential differences in stent expansion
among transplant patients vs. patients with native coronary artery atherosclerotic
disease (“controls”).
Methods: We compared pre and post-stent intravascular ultrasound in 12 transplant
patients (17 lesions) and 33 control patients (34 lesions) matched according to age
(60.1±9.2 years), diabetes mellitus, and lesion location. Planar and volumetric analysis
was conducted for every 1 mm at the lesion site as well as the first 5 mm proximal and
distal to the stent edge. Focal stent expansion was defined as minimum stent area
(MSA) divided by mean reference lumen area. Diffuse stent expansion was defined as
mean stent area divided by mean reference lumen area.
Results: Transplant patients had more plaque than “controls” pre-stenting, but similar
MSA and focal and diffuse stent expansion afterwards. The increase in mean lumen
area correlated with the increase in mean vessel area in both groups - transplant
(R=0.64, p=0.008) and controls (R=0.70, p<0.0001), but correlated inversely with
changes in mean plaque area only in the transplant group (R=0.55, p=0.027) – Fig 1.
There were no differences in calcification between the two groups and no axial plaque
distribution from the lesion into the reference segments in either group.
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Conclusion: The mechanism of stent expansion in transplant vasculopathy appears to
be similar to de novo atherosclerosis - i.e. mainly vessel expansion to achieve similar
acute results.
TCT-682
Impact Of Plaque Composition On Post-Procedural Myocardial Injury During
Stent Implantation: a Meta-Analysis
Jae-Sik Jang1, Sang-Ryul Chung1, Han-Young Jin1, Jeong-Sook Seo1, Tae-Hyun
Yang1, Dae-Kyeong Kim1, Dong-Soo Kim1, Bomin Park2, Dong-Kie Kim2, Sang-
Hoon Seol2, Doo-Il Kim2
1Cardiology, Inje University Busan Paik Hospital, Busan, Republic of Korea; 2Inje
University Haeundae Paik Hospital, Busan, Republic of Korea
Background: There are controversies in the association between plaque composition
and myocardial injury after percutaneous coronary intervention (PCI). We therefore
conducted a systematic review and meta-analysis to evaluate characteristic morphology
and composition of atherosclerotic plaque observed by grayscale and virtual histology-
intravascular ultrasound (VH-IVUS) in patients with myocardial injury after PCI.
Methods: We searched PubMed and MEDLINE databases for IVUS studies evaluating
coronary plaque characteristics in no-reflow, distal embolization phenomenon, and
periprocedural myocardial infarction following PCI. Pooled weighted mean difference
(WMD) and pooled odds ratio (OR) with 95% confidence intervals (CIs) were
calculated.
Results: Sixteen studies have been included totaling 1,697 patients who underwent
PCI (292 patients with myocardial injury and 1,405 patients without myocardial
injury). In the myocardial injury group, vessel cross-sectional area and amount of
plaque burden in the culprit lesion were significantly greater than in the no myocardial
injury group (p<0.001). Pooled analysis showed that absolute necrotic core volume
(WMD 4.65, 95% CI 1.00–8.31, p=0.01), absolute (WMD 0.73, 95% CI 0.14–1.31,
p=0.01) and relative (WMD 11.2, 95% CI 7.88–14.17, p<0.001) necrotic core areas at
the minimum lumen sites were significantly greater in the myocardial injury group
compared with the no myocardial injury group.
Mean differences and odds ratios of IVUS findings according to the presence of
myocardial injury.
Conclusion: In addition to morphologic characteristics of plaque derived from
grayscale IVUS, the necrotic core component derived from VH-IVUS is closely related
to the myocardial injury after PCI.
TCT-683
Prediction of distal embolization during percutaneous coronary intervention for
unstable plaques with grayscale and integrated backscatter intravascular
ultrasound
Daisuke Morisawa1, Atsunori Okamura1, Masahiko Shibuya2, Motoo Date1,
Yoshiharu Higuchi1, Hiroyuki Nagai1, Shimpei Nakatani1, Katsuomi Iwakura1,
Kenshi Fujii1
1Cardiovascular division, Sakurabashi-Watanabe hospital, Osaka, Japan; 2Hyogo
college of medicine,Cardiology medicine, Nishinomiya, Japan
Background: We performed microscopic examination of the debris collected by a
distal protection device and investigated the usefulness of grayscale and integrated
backscatter intravascular ultrasound (IB-IVUS) for prediction of distal embolization
during percutaneous coronary intervention (PCI) in cases of unstable angina. The
prediction of distal embolization during PCI has not been studied in depth because
assessment of distal embolization is difficult.
Methods: We prospectively studied 34 consecutive patients with unstable angina who
underwent PCI with a filter distal protection device. The pre-procedural plaque volume
at target lesions was measured with grayscale IVUS and plaque characteristics were
assessed with IB-IVUS. We performed microscopic examination of the particles
collected by the distal protection device.
Results: There was a significant correlation between the plaque volume and the
number of the collected particles > 100 μm in diameter (r = 0.48, P = 0.0034). Filter
no-reflow (FNR) phenomenon was found in 9 patients. The plaque volume was
significantly greater (355 ± 133 mm3 vs. 199 ± 90 mm3 P = 0.0004), and the lipid
ratio was significantly higher (29.3 ± 4.3% vs. 26.1 ± 4.3 P = 0.045) in the FNR group
compared to the non-FNR group. Multivariate logistic regression analysis showed that
the plaque volume was an independent predictor of FNR phenomenon.
Conclusion: Although tissue characterization of IB-IVUS may provide additional
information for distal embolization, plaque volume is the only significant predictor of
distal embolization during PCI and a distal protection device will be useful for patients
with large plaque volume.
TCT-684
Title: Detection of > 0.4 mm of Minimal Intimal Thickness During Routine
Intracoronary Ultrasound Studies Without a Baseline Study Correlates
strongly with Total Death and Adverse Outcomes in Cardiac Transplant
Patients
Reza Arsanjani1, 2, Avinash Khitri2, Mehrnoosh Hashemzadeh2, Mohammad Reza
Movahed1, 2
1The Southern Arizona VA Health Care System, Tucson, AZ; 2University of Arizona
Sarver Heart Center, Tucson, AZ
Background: Routine yearly coronary angiography is the gold standard for detection
of cardiac transplant vasculopathy (CTV). However, abnormal minimal intimal
thickening (MIT) found on IVUS defined as difference of > 0.4 mm between baseline
and one year post-transplantation has been shown to have significant prognostic value.
The goal of this study was to evaluate whether performing the first IVUS more than 6
months after cardiac transplantation without a baseline IVUS would have similar
prognostic value.
Methods: A cohort of 148 cardiac transplant patients who underwent IVUS
examination more than 6 months post transplant at the University Medical Center from
1999-2008 without a baseline study were evaluated retrospectively. MIT values of >
0.4 mm were correlated with major adverse cardiac event (MACE) and all cause
mortality.
Results: Abnormal baseline MIT of >/= 0.5 mm showed a significant correlation with
total death. [5/107 (4.7%) vs. 6/41 (14.6%), OR 3.2, CI 1.002-12.17, p=0.039] and
MACE. [9/107 (8.4%) vs. 10/41 (24.4%), OR 6.7, CI 1.30-9.42, p=0.0090]. Using
multivariate analysis adjusting for age, abnormal MIT remained a significant
independent predictor of MACE (OR 3.93, CI 1.21-12.81, p=0.023).
Conclusion: The presence of abnormal MIT noted on IVUS performed anytime after
6 months post transplantation without a baseline IVUS study, carries a strong
prognostic value in cardiac transplant patients. Our study suggests that a baseline IVUS
study may not be needed for detection of prognostic MIT. This simplified approach
can lead to lower costs and ease of use in this patient population.
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